库欣综合征及丙酸氯倍他索所致的垂体-肾上腺抑制
Cushing's syndrome and pituitary-adrenal suppression due to clobetasol propionate.
作者信息
Staughton R C, August P J
出版信息
Br Med J. 1975 May 24;2(5968):419-21. doi: 10.1136/bmj.2.5968.419.
Abstract
Widespread application of clobetasol propionate resulted in suppression of the hypothalamic pituitary axis in four patients. Three patients showed Cushigoid features and developed symptoms of adrenocortical insufficiency on withdrawal of clobetasol.
摘要
四名患者广泛应用丙酸氯倍他索后出现下丘脑 - 垂体轴抑制。三名患者出现库欣样特征，停用丙酸氯倍他索后出现肾上腺皮质功能不全症状。
相似文献
1
Cushing's syndrome and pituitary-adrenal suppression due to clobetasol propionate.库欣综合征及丙酸氯倍他索所致的垂体-肾上腺抑制
Br Med J. 1975 May 24;2(5968):419-21. doi: 10.1136/bmj.2.5968.419.
2
Hypothalamus-pituitary-adrenal axis suppression by superpotent topical steroids.
J Am Acad Dermatol. 1993 Sep;29(3):501-3. doi: 10.1016/s0190-9622(08)82011-7.
3
Adrenal suppression following low-dose topical clobetasol propionate.低剂量外用丙酸氯倍他索后的肾上腺抑制
J R Soc Med. 1987 Jul;80(7):422-4. doi: 10.1177/014107688708000709.
4
Clobetasone butyrate, a new topical corticosteroid: clinical activity and effects on pituitary-adrenal axis function and model of epidermal atrophy.丁酸氯倍他松，一种新型外用皮质类固醇：临床活性及其对垂体-肾上腺轴功能和表皮萎缩模型的影响
Br Med J. 1975 Sep 13;3(5984):626-8. doi: 10.1136/bmj.3.5984.626.
5
6
Clobetasol propionate emulsion formulation foam 0.05%: review of phase II open-label and phase III randomized controlled trials in steroid-responsive dermatoses in adults and adolescents.丙酸氯倍他索乳剂配方泡沫0.05%：成人和青少年类固醇反应性皮肤病的II期开放标签和III期随机对照试验综述
J Am Acad Dermatol. 2008 Sep;59(3):448-54, 454.e1. doi: 10.1016/j.jaad.2008.04.020. Epub 2008 Jun 9.
7
Unrecognised Cushing's syndrome and adrenal suppression due to topical clobetasol propionate.因外用丙酸氯倍他索导致的未被识别的库欣综合征和肾上腺抑制。
Br J Clin Pract. 1991 Spring;45(1):61-2.
8
Effect of calcipotriene plus betamethasone dipropionate topical suspension on the hypothalamic-pituitary-adrenal axis and calcium homeostasis in subjects with extensive psoriasis vulgaris: an open, non-controlled, 8-week trial.卡泊三醇倍他米松二丙酸酯外用混悬液对重度寻常型银屑病患者下丘脑-垂体-肾上腺轴及钙稳态的影响：一项开放、非对照的8周试验。
J Drugs Dermatol. 2013 Aug;12(8):882-7.
9
[Assessment of value and risks of external treatment with clobetasol-17-propionate (Dermovate)].[丙酸氯倍他索（得宝松）外用治疗的价值与风险评估]
Ned Tijdschr Geneeskd. 1978 Feb 18;122(7):219-23.
10
Short- and long-term safety assessment of a two-compound ointment containing calcipotriene/betamethasone dipropionate (Taclonex/Daivobet/Dovobet ointment): hypothalamic-pituitary-adrenal axis function in patients with psoriasis vulgaris.含有卡泊三醇/倍他米松二丙酸酯的复方软膏（他卡西醇/得肤宝/达力士软膏）的短期和长期安全性评估：寻常型银屑病患者的下丘脑-垂体-肾上腺轴功能
J Drugs Dermatol. 2010 Aug;9(8):969-74.
引用本文的文献
1
Hypothalamus-pituitary-adrenal axis (HPA axis) suppression with inappropriate use of steroids in recalcitrant dermatophytosis - A cross-sectional study.顽固性皮肤癣菌病中不适当使用类固醇导致下丘脑-垂体-肾上腺轴（HPA轴）抑制——一项横断面研究。
J Family Med Prim Care. 2024 May;13(5):2026-2031. doi: 10.4103/jfmpc.jfmpc_1330_23. Epub 2024 May 24.
2
Novel Dermal Delivery Cargos of Clobetasol Propionate: An Update.丙酸氯倍他索新型皮肤给药载体：最新进展
Pharmaceutics. 2022 Feb 9;14(2):383. doi: 10.3390/pharmaceutics14020383.
3
Novel Predictive Model for Adrenal Insufficiency in Dermatological Patients with Topical Corticosteroids Use: A Cross-Sectional Study.使用局部皮质类固醇的皮肤病患者肾上腺功能不全的新型预测模型：一项横断面研究。
Int J Gen Med. 2021 Nov 12;14:8141-8147. doi: 10.2147/IJGM.S342841. eCollection 2021.
4
Systemic side-effects of topical corticosteroids.局部用皮质类固醇的全身性副作用。
Indian J Dermatol. 2014 Sep;59(5):460-4. doi: 10.4103/0019-5154.139874.
5
Importance of a thorough drug history in presurgical patients.术前患者全面用药史的重要性。
BMJ Case Rep. 2014 Mar 14;2014:bcr2013202667. doi: 10.1136/bcr-2013-202667.
6
Exogenous Cushing's syndrome due to topical corticosteroid application: case report and review literature.因局部皮质类固醇应用引起的外源性库欣综合征：病例报告及文献复习。
Endocrine. 2010 Dec;38(3):328-34. doi: 10.1007/s12020-010-9393-6. Epub 2010 Oct 23.
7
Emotional lability secondary to the application of a very potent topical corticosteroid.因使用强效外用皮质类固醇而出现情绪不稳定。
Indian J Psychiatry. 2009 Jul-Sep;51(3):212-3. doi: 10.4103/0019-5545.55093.
8
The role of topical corticosteroids in bullous pemphigoid in the elderly.外用糖皮质激素在老年大疱性类天疱疮中的作用。
Drugs Aging. 2005;22(7):571-6. doi: 10.2165/00002512-200522070-00003.
9
Epidermal thinning: evaluation of commercial corticosteroids.表皮变薄：市售皮质类固醇的评估
Arch Dermatol Res. 1980;267(1):7-24. doi: 10.1007/BF00416917.
10
Adrenal suppression following low-dose topical clobetasol propionate.低剂量外用丙酸氯倍他索后的肾上腺抑制
J R Soc Med. 1987 Jul;80(7):422-4. doi: 10.1177/014107688708000709.
本文引用的文献
1
THE ADRENOCORTICAL RESPONSE TO INSULIN-INDUCED HYPOGLYCAEMIA.肾上腺皮质对胰岛素诱导的低血糖的反应。
J Endocrinol. 1963 Nov;27:183-92. doi: 10.1677/joe.0.0270183.
2
Percutaneous absorption of corticosteroids: systemic effects.
N Engl J Med. 1965 Oct 14;273(16):831-40. doi: 10.1056/NEJM196510142731601.
3
Adrenal and pituitary functions during long-term topical steroid therapy.长期局部应用类固醇治疗期间的肾上腺和垂体功能。
Dermatologica. 1972;144(3):179-86. doi: 10.1159/000252115.
4
The effect on plasma corticosteroid levels of the short term topical application of clobetasol propionate.
Br J Dermatol. 1974 Sep;91(3):339-43. doi: 10.1111/j.1365-2133.1974.tb12904.x.
5
Pustular psoriasis with adrenal suppression following topical corticosteroids.外用糖皮质激素后出现肾上腺抑制的脓疱型银屑病。
Proc R Soc Med. 1974 Aug;67(8):719-20. doi: 10.1177/003591577406700813.
6
Some studies of the protein-binding of steroids and their application to the routine micro and ultramicro measurement of various steroids in body fluids by competitive protein-binding radioassay.一些关于类固醇蛋白质结合的研究及其在通过竞争性蛋白质结合放射分析法对体液中各种类固醇进行常规微量和超微量测量中的应用。
J Clin Endocrinol Metab. 1967 Jul;27(7):973-90. doi: 10.1210/jcem-27-7-973.
7
Generalized pustular psoriasis. A clinical and epidemiological study of 104 cases.泛发性脓疱型银屑病。104例临床与流行病学研究。
Br J Dermatol. 1968 Dec;80(12):771-93. doi: 10.1111/j.1365-2133.1968.tb11947.x.
8
Pituitary-adrenal function after occlusive topical therapy with betamethasone-17-valerate.倍他米松-17-戊酸酯局部封闭治疗后的垂体-肾上腺功能
Lancet. 1967 Nov 18;2(7525):1059-61. doi: 10.1016/s0140-6736(67)90336-4.
Zotero 插件